Research programme: Chagas disease vaccines - Gador/SEEK

Drug Profile

Research programme: Chagas disease vaccines - Gador/SEEK

Latest Information Update: 24 Dec 2010

Price : $50

At a glance

  • Originator PepTcell
  • Developer SEEK
  • Class Vaccines
  • Mechanism of Action T lymphocyte stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Research Chagas disease

Most Recent Events

  • 20 Oct 2009 Development is ongoing in the UK
  • 17 Dec 2007 Early research in Chagas' disease in United Kingdom (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top